1 Executive Summary 2 Preface 2.1 Abstract 2.2 Stake Holders 2.3 Research Scope 2.4 Research Methodology 2.4.1 Data Mining 2.4.2 Data Analysis 2.4.3 Data Validation 2.4.4 Research Approach 2.5 Research Sources 2.5.1 Primary Research Sources 2.5.2 Secondary Research Sources 2.5.3 Assumptions 3 Market Trend Analysis 3.1 Introduction 3.2 Drivers 3.3 Restraints 3.4 Opportunities 3.5 Threats 3.6 Application Analysis 3.7 End User Analysis 3.8 Emerging Markets 3.9 Futuristic Market Scenario 4 Porters Five Force Analysis 4.1 Bargaining power of suppliers 4.2 Bargaining power of buyers 4.3 Threat of substitutes 4.4 Threat of new entrants 4.5 Competitive rivalry 5 Global Viral Vector Manufacturing Market, By Type 5.1 Introduction 5.2 Adenoviral Vectors 5.3 Retroviral Vectors 5.3.1 Gamma-Retroviral Vectors 5.3.2 Lentiviral Vectors 5.4 Adeno-Associated Viral Vectors 5.5 Pox Virus 5.6 Cytomegalovirus 5.7 Other Types 5.7.1 Herpes Simplex Virus Vectors 6 Global Viral Vector Manufacturing Market, By Disease 6.1 Introduction 6.2 Human Disease 6.2.1 Infectious Diseases 6.2.1.1 Influenza 6.2.1.2 Malaria 6.2.1.3 Hepatitis 6.2.2 Genetic Disorders 6.2.2.1 Human Immunodeficiency Virus (HIV) 6.2.2.2 Tuberculosis 6.2.3 Cancer 6.2.4 Other Human Diseases 6.3 Veterinary Disease 6.3.1 Avian Influenza 6.3.2 Marek's Disease 6.3.3 Infectious Bronchitis 6.3.4 Peste des Petits Ruminants (PPR) Disease 6.3.5 Other Veterinary Diseases 6.3.5.1 Rabies 6.3.5.2 Fibromuscular Dysplasia (FMD) 6.3.5.3 Swine Influenza 6.3.5.4 Equine Influenza 6.3.5.5 Newcastle Disease 7 Global Viral Vector Manufacturing Market, By Application 7.1 Introduction 7.2 Vaccinology 7.2.1 Multivalent Vaccines 7.2.2 Multipathogen Vaccines 7.3 Gene Therapy 8 Global Viral Vector Manufacturing Market, By End User 8.1 Introduction 8.2 Research Institutes 8.3 Pharmaceutical and Biopharmaceutical Companies 8.4 Other End Users 9 Global Viral Vector Manufacturing Market, By Geography 9.1 Introduction 9.2 North America 9.2.1 US 9.2.2 Canada 9.2.3 Mexico 9.3 Europe 9.3.1 Germany 9.3.2 UK 9.3.3 Italy 9.3.4 France 9.3.5 Spain 9.3.6 Rest of Europe 9.4 Asia Pacific 9.4.1 Japan 9.4.2 China 9.4.3 India 9.4.4 Australia 9.4.5 New Zealand 9.4.6 South Korea 9.4.7 Rest of Asia Pacific 9.5 South America 9.5.1 Argentina 9.5.2 Brazil 9.5.3 Chile 9.5.4 Rest of South America 9.6 Middle East & Africa 9.6.1 Saudi Arabia 9.6.2 UAE 9.6.3 Qatar 9.6.4 South Africa 9.6.5 Rest of Middle East & Africa 10 Key Developments 10.1 Agreements, Partnerships, Collaborations and Joint Ventures 10.2 Acquisitions & Mergers 10.3 New Product Launch 10.4 Expansions 10.5 Other Key Strategies 11 Company Profiling 11.1 Spark Therapeutics 11.2 Uniqure 11.3 Kaneka Eurogentec 11.4 Regenxbio 11.5 Finvector Vision Therapies 11.6 Novasep 11.7 Massbiologics 11.8 Merck KGaA 11.9 Cobra Biologics 11.10 Fujifilm Holdings Corporation 11.11 Lonza 11.12 Brammer Bio 11.13 Oxford Biomedica 11.14 Thermo Fisher Scientific Inc. List of Tables 1 Global Viral Vector Manufacturing Market Outlook, By Region (2016-2026) ($MN) 2 Global Viral Vector Manufacturing Market Outlook, By Type (2016-2026) ($MN) 3 Global Viral Vector Manufacturing Market Outlook, By Adenoviral Vectors (2016-2026) ($MN) 4 Global Viral Vector Manufacturing Market Outlook, By Retroviral Vectors (2016-2026) ($MN) 5 Global Viral Vector Manufacturing Market Outlook, By Gamma-Retroviral Vectors (2016-2026) ($MN) 6 Global Viral Vector Manufacturing Market Outlook, By Lentiviral Vectors (2016-2026) ($MN) 7 Global Viral Vector Manufacturing Market Outlook, By Adeno-Associated Viral Vectors (2016-2026) ($MN) 8 Global Viral Vector Manufacturing Market Outlook, By Pox Virus (2016-2026) ($MN) 9 Global Viral Vector Manufacturing Market Outlook, By Cytomegalovirus (2016-2026) ($MN) 10 Global Viral Vector Manufacturing Market Outlook, By Other Types (2016-2026) ($MN) 11 Global Viral Vector Manufacturing Market Outlook, By Herpes Simplex Virus Vectors (2016-2026) ($MN) 12 Global Viral Vector Manufacturing Market Outlook, By Disease (2016-2026) ($MN) 13 Global Viral Vector Manufacturing Market Outlook, By Human Disease (2016-2026) ($MN) 14 Global Viral Vector Manufacturing Market Outlook, By Infectious Diseases (2016-2026) ($MN) 15 Global Viral Vector Manufacturing Market Outlook, By Genetic Disorders (2016-2026) ($MN) 16 Global Viral Vector Manufacturing Market Outlook, By Cancer (2016-2026) ($MN) 17 Global Viral Vector Manufacturing Market Outlook, By Other Human Diseases (2016-2026) ($MN) 18 Global Viral Vector Manufacturing Market Outlook, By Veterinary Disease (2016-2026) ($MN) 19 Global Viral Vector Manufacturing Market Outlook, By Avian Influenza (2016-2026) ($MN) 20 Global Viral Vector Manufacturing Market Outlook, By Marek's Disease (2016-2026) ($MN) 21 Global Viral Vector Manufacturing Market Outlook, By Infectious Bronchitis (2016-2026) ($MN) 22 Global Viral Vector Manufacturing Market Outlook, By Peste des Petits Ruminants (PPR) Disease (2016-2026) ($MN) 23 Global Viral Vector Manufacturing Market Outlook, By Other Veterinary Diseases (2016-2026) ($MN) 24 Global Viral Vector Manufacturing Market Outlook, By Application (2016-2026) ($MN) 25 Global Viral Vector Manufacturing Market Outlook, By Vaccinology (2016-2026) ($MN) 26 Global Viral Vector Manufacturing Market Outlook, By Multivalent Vaccines (2016-2026) ($MN) 27 Global Viral Vector Manufacturing Market Outlook, By Multipathogen Vaccines (2016-2026) ($MN) 28 Global Viral Vector Manufacturing Market Outlook, By Gene Therapy (2016-2026) ($MN) 29 Global Viral Vector Manufacturing Market Outlook, By End User (2016-2026) ($MN) 30 Global Viral Vector Manufacturing Market Outlook, By Research Institutes (2016-2026) ($MN) 31 Global Viral Vector Manufacturing Market Outlook, By Pharmaceutical and Biopharmaceutical Companies (2016-2026) ($MN) 32 Global Viral Vector Manufacturing Market Outlook, By Other End Users (2016-2026) ($MN) Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.